BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27
• 30

• Press Releases

  Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - September 9, 2024

  September 10, 2024

   · 

  6 min read
• Press Releases

  Champions Oncology to Announce First Quarter Financial Results on Wednesday, September 11, 2024

  September 10, 2024

   · 

  1 min read
• Press Releases

  Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - September 9, 2024

  September 10, 2024

   · 

  2 min read
• Press Releases

  Ionis announces proposed public offering of common stock

  September 10, 2024

   · 

  4 min read
• Press Releases

  UPDATE - Aprea Therapeutics to Present at the H.C. Wainwright Annual Global Investment Conference

  September 10, 2024

   · 

  1 min read
• Press Releases

  Ionis announces pricing of $500.3 million public offering

  September 10, 2024

   · 

  4 min read
• Press Releases

  SENISCA appoints Tim Edwards as Chair of the Board

  September 10, 2024

   · 

  3 min read
• Press Releases

  Updated Data from Phase II Clinical Trial of Iruplinalkib Tablets (Qixinke®) Presented at World Conference on Lung Cancer 2024

  September 10, 2024

   · 

  2 min read
• Press Releases

  Aclarion Announces Completion of First Nociscan Exams in LIFEHAB Trial

  September 10, 2024

   · 

  4 min read
• Press Releases

  Roivant Unveils New Pipeline Program Mosliciguat, A Potential First-In-Class and Best-In-Category Inhaled Once-Daily Soluble Guanylate Cyclase (sGC) Activator

  September 10, 2024

   · 

  9 min read